bet365 es

bet365 es Advancements in HDR Technology at IFFI 2024 - Observer VoiceAlabama and Mississippi tumbled out of the top 10 of The Associated Press Top 25 poll Sunday and Miami and SMU moved in following a chaotic weekend in the SEC and across college football in general. Oregon is No. 1 for the sixth straight week and Ohio State, Texas and Penn State held their places behind the Ducks, who are the last unbeaten team. The shuffling begins at No. 5, where Notre Dame returned for the first time since Week 2 after beating Army for its ninth straight win. No. 6 Georgia moved up two spots, No. 7 Tennessee and No. 8 Miami each got a three-rung promotion and No. 9 SMU jumped four places for its first top-10 ranking since 1985. SMU has clinched a spot in the Atlantic Coast Conference title game and would play Miami, if the Hurricanes win at Syracuse this week, or No. 12 Clemson . Indiana dropped from No. 5 to No. 10 following its first loss, a 38-15 defeat at Ohio State. The Buckeyes would play Oregon in the Big Ten championship game if they beat Michigan this Saturday for the first time in four years. The Southeastern Conference's hopes for landing four spots in the College Football Playoff took a hit with two of their teams losing as double-digit favorites. Texas, Georgia and Tennessee are the only SEC teams with fewer than three losses after Alabama lost 24-3 at Oklahoma and Mississippi lost 24-17 at Florida. Alabama and Mississippi each dropped six spots in the AP poll, the Crimson Tide to No. 13 and the Rebels to No. 15. Texas A&M was the third SEC team to lose, 43-41 at Auburn in four overtimes. The Aggies tumbled five places to No. 20 but would play Georgia in the SEC championship game if they knock off Texas this week. Losses by BYU and Colorado created a four-way tie for first in the Big 12. No. 14 Arizona State, picked to finish last in the conference, handed BYU its second straight loss and is the highest-ranked Big 12 team. No. 17 Iowa State earned a five-rung promotion with its win at Utah. BYU is No. 19 and Colorado, which lost to Kansas , is No. 23. If the four teams each finish 7-2 in conference play, it's Iowa State vs. Arizona State in the Big 12 championship game. No. 11 Boise State is first among the four ranked Group of Five teams. The Broncos got a one-spot bump despite struggling to beat a two-win Wyoming team. Tulane is No. 18, UNLV is No. 21 and Army is No. 25. Oregon, which was idle, was the consensus No. 1 team for the fourth straight week. The Ducks will be unbeaten in the regular season for the first time since 2010 if they beat Washington at home Saturday. Boise State's ranking is its highest since it was No. 8 in the final poll of the 2011 season. Arizona State's ranking is its highest since it was No. 12 in the final poll of the 2014 season. Indiana-Ohio State was the final top-five matchup of the regular season. The five were the most in a regular season since 1996. There also were five in 1936 and 1943. No. 24 Missouri, a 39-20 winner at Mississippi State , returned to the Top 25 after a one-week absence. Washington State's four-week run in the rankings ended with its second straight loss, 41-38 loss at Oregon State. SEC — 8 (Nos. 3, 6, 7, 13, 15, 16, 20, 24). Big Ten — 5 (Nos. 1, 2, 4, 10, 22). Big 12 — 4 (Nos. 14, 17, 19, 23). ACC — 3 (Nos. 8, 9, 12). AAC — 2 (Nos. 18, 25). Mountain West — 2 (Nos. 11, 21). Independent — 1 (No. 5). —No. 16 South Carolina at No. 12 Clemson: It's a Top 25 matchup for the first time since 2013. Clemson's 16-7 victory in Columbia last year was the fourth of five straight wins to end the Tigers' season. —No. 3 Texas at No. 20 Texas A&M: Stakes are high for the first meeting of longtime rivals since both were in the Big 12 in 2011. Winner goes to the SEC title game. Get poll alerts and updates on the AP Top 25 throughout the season. Sign up here . AP college football: https://apnews.com/hub/ap-top-25-college-football-poll and https://apnews.com/hub/college-footballMumbai: The State Cyber Police have registered a case against 12 social media users for posting an offensive video on social media, alleging that Maharashtra Chief Minister Devendra Fadnavis does not believe in the Indian Constitution, democracy, or any constitutional institution and suggesting his goal is to establish a parallel state. The action was taken based on a complaint filed by a representative of the Bharatiya Janata Party (BJP). According to the State Cyber Police, the accused users—India Bhavla Shinde (@Bs131B), Shuddhodhan Sahjrao (@Suddhodhan74629), Nagpur Congress Sevadal (@SevadalNGP), Saurabh Singh Chauhan (@Sbchauhan0103), Mukesh Lavhale (@Lavhale), Prasad Salvi, Varad Kanki, Amol Kamble, Syed Salim, THE SMART 230K, and Vishnu Bhotkar are accused of sharing an edited and incomplete video. The complaint alleged that these social media users posted defamatory content on platforms like Twitter (X Handle), Facebook, Instagram, and YouTube with the intent to incite public harm and disturb Maharashtra’s law and order situation. The FIR have registered under Sections 353(1)(B), 356(2), 192, 3(5) of the BNS Act with Section 67 of the Information Technology (IT) Act, 2000 against the social media users responsible for posting the objectionable video. Notices have been issued to all social media intermediaries to provide information on these accused handles. The initial investigation by the State Cyber Police revealed that the video was deliberately taken out of context to falsely portray the Chief Minister as opposing constitutional values and intending to establish a parallel governance system. The video appears to be designed to provoke social unrest, hurt the sentiments of specific groups, and potentially disrupt Maharashtra's law and order.

ROURKELA: The charred body of a Plus II student along with his fully gutted scooter was found from a torched hay stack in Sargipali under Lefripada police limits in Sundargarh district on Friday. Police suspect Mahesh Pradhan, 19, may have been murdered and the body burnt in the hay stack near the Navodaya Vidyalaya late on Thursday night. The location where the incident took place is barely 1 km from Sargipali police outpost and about 140 km from Rourkela. The incident came to light after villagers on early Friday morning saw the charred body and the two-wheeler before informing police. Initially, the body could not be identified and police identified victim as Mahesh Pradhan using the chassis number of the gutted vehicle. Mahesh was son of Duryodhar Pradhan residing near the regulated market committee complex at Sargipali. Sundargarh SP Pratyush Diwakar visited the site to take stock of the situation and police sent the body for autopsy to Sundargarh district headquarters hospital. Diwakar said preliminary investigation revealed Mahesh was last seen going out on his scooter on Thursday night and did not return home. While investigation is underway from all angles, the SP said, prima facie it appeared the victim may have met with an accident and hit the paddy straw stack. That might have led to a fire that reduced everything to ashes. Diwakar said an unnatural death case has been registered and phone call records of the 19-year-old are being analysed to know about his movement on Thursday night. If anything suspicious is found, the case would be converted accordingly. The SP said there was no struggle mark on the site to suggest foul play and his family members also did not cite any such possibility. The location is along a yet-to-be-opened newly-constructed road on the outskirts of Sargipali and seldom frequented by local villagers.Doximity ( NASDAQ:DOCS – Free Report ) had its price target upped by JPMorgan Chase & Co. from $30.00 to $48.00 in a research note issued to investors on Thursday, Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock. Several other equities research analysts have also recently issued reports on the company. Bank of America raised their target price on Doximity from $32.00 to $45.00 and gave the stock a “neutral” rating in a research note on Monday, October 7th. Raymond James restated an “outperform” rating and set a $65.00 price target (up from $37.00) on shares of Doximity in a research report on Friday, November 8th. Evercore ISI raised their price target on Doximity from $34.00 to $45.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Baird R W upgraded Doximity to a “strong-buy” rating in a research report on Tuesday, September 17th. Finally, Canaccord Genuity Group restated a “hold” rating and set a $60.00 price target (up from $40.00) on shares of Doximity in a research report on Wednesday, November 13th. Eleven investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Doximity presently has a consensus rating of “Hold” and an average price target of $52.27. Get Our Latest Research Report on Doximity Doximity Stock Up 0.4 % Institutional Inflows and Outflows Hedge funds and other institutional investors have recently bought and sold shares of the stock. MetLife Investment Management LLC lifted its holdings in Doximity by 0.6% during the 3rd quarter. MetLife Investment Management LLC now owns 65,064 shares of the company’s stock worth $2,835,000 after buying an additional 363 shares during the last quarter. First Horizon Advisors Inc. lifted its holdings in Doximity by 22.5% during the 3rd quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company’s stock worth $91,000 after buying an additional 384 shares during the last quarter. GAMMA Investing LLC lifted its holdings in Doximity by 40.1% during the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after buying an additional 412 shares during the last quarter. Van ECK Associates Corp lifted its holdings in Doximity by 19.7% during the 2nd quarter. Van ECK Associates Corp now owns 2,590 shares of the company’s stock worth $72,000 after buying an additional 427 shares during the last quarter. Finally, Cornercap Investment Counsel Inc. lifted its holdings in Doximity by 3.2% during the 2nd quarter. Cornercap Investment Counsel Inc. now owns 17,143 shares of the company’s stock worth $479,000 after buying an additional 537 shares during the last quarter. 87.19% of the stock is currently owned by hedge funds and other institutional investors. About Doximity ( Get Free Report ) Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. Further Reading Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter .DONALD Trump's "petty" hush money case has made "a mockery of the criminal justice system," an attorney has claimed. Trump 's sentencing over payments to former porn star Stormy Daniels has been delayed indefinitely following a decision by a New York judge on Friday. But David Gelman, the founding attorney of New Jersey-based Gelman Law , LLC, told The U.S. Sun the New York hush-money case needed to be dismissed completely. The president-elect was facing four years in prison over payments made by his former lawyer, Michael Cohen , to adult film actress Daniels to cover up an affair she alleges the pair had in 2016. Trump has denied the affair. Earlier this week, prosecuting attorney Alvin Bragg, a Democrat, accepted that any sentencing was unlikely in the wake of Trump's election victory. READ MORE ON DONALD TRUMP However, he said that Trump could still face sentencing following the conclusion of his second term, in 2029, by which time he would 83. "It's very petty," Gelman said. "When President Trump is out of office, he would be 83." "It's really an injustice what they're doing. Honestly, it's a mockery of the criminal justice system." Gelman said there is a presumption against non-incarceration for Trump because he has never been charged or convicted of a crime . Most read in The US Sun "It's very uncharted territory because you've never had a president be charged criminally," he said. "Furthermore, I think it's also a due process violation to wait until 2029." By 2029, Gelman said, we will be living in a "whole other world." "Who knows if Alvin Bragg will even be the DA in 2029?" he said. "Who knows if Judge Merchan will even be the judge in 2029? I would venture to guess no for both." Gelman called on Judge Merchan to "do the right thing for once" by "dismissing this case in its entirety." Attention now turns to December 2, the date by which Trump's lawyers must submit the additional papers as part of their argument that the case should be dismissed. LEADING Florida-based trial attorney Betty Dunkum spoke to The U.S. Sun about what the delay in Trump's hush-money case in New York could mean. "There are a lot of legal issues, called immunities, that affect the President and even the President-elect during the transition. "Those immunities extend to things like Presidents, need to be free to conduct presidential business, and cannot be hindered by prosecutions, and so the law in layman's terms prevents prosecutors from bringing or continuing cases during a president's time in office. "The Trump team is going to move to completely dismiss the case. That will obviously be briefed and worked out as the months go on. "In terms of his second term in office in terms of the policies and what he is going to be doing, he had an agenda that he was already setting forth through the executive orders. So that policy will continue. I think the way it impacts Trump is more personally. "Whether or not this case will now be heard in 2029, that is bumping up against some United States case law. There is case law from New York and other jurisdictions governing the delay in sentencing. "And there is old case law saying that if there is an unreasonable delay in sentencing, then the court could lose its jurisdiction over the case. Everything related to what's going on with Donald Trump in these criminal cases is new in the legal system. It's never happened before, and so judges are always very careful about when they branch into new territory. "Generally, they want to always try to stand on as many prior decisions as possible, and so, because there is so much new here. There are a lot of issues that are what we call in legal terms issues of first impression. So it complicates things. "This case is not over until it's over. There's just a lot of bumps in the road for those prosecutions, because Trump is president now, and everything will need to be delayed." The prosecution then has until December 9 to respond. Gelman believes Trump's next legal move will be to "file a motion to dismiss the matter altogether." For reasons of "judicial economy," as well as the fact Trump would have had immunity at the time of the charges, Gelman says Trump's team will push for dismissal. As for the impact of the outstanding sentencing on Trump's second term, Gelman said it will be "Nothing. Literally, absolutely, 100% nothing." He described the entire case as "100% politically motivated," with the goal to "keep President Trump off of the campaign trail." Gelman said the move had "totally backfired" thanks to Trump's landslide victory over Harris. "He won the electoral college, he won the popular vote, and it wasn't even close," he said. "So, the American people saw that this was a weaponization of the DOJ against President Trump." Read More on The US Sun Gelman went on, "It was a weaponization by Alvin Bragg's office against President Trump. "And by what they're doing now is they're doubling down because they have egg on their face."Chuck Woolery, smooth-talking game show host of 'Love Connection' and 'Scrabble,' dies at 83

India's car race: How far EVs went in 2024None

Here, the veteran chef tells how he built up one of the most successful seafood restaurants in the Scottish capital, and his thirst for expansion. Business name: Chef and owner of Ondine Oyster & Grill Location: Seaton House, St Andrews, and Edinburgh Business Description: Ondine Oyster & Grill, specialising in seafood and shellfish, was opened in 2009 by renowned owner and chef Roy Brett, one of Scotland's leading figures in the food revolution. It has since become an institution within the heart of Edinburgh's Old Town. We are delighted to announce that in early 2025, Ondine will be relocating to a brand-new venue in Edinburgh city centre, and opening at Seaton House Hotel in St Andrews in spring 2025. After 15 very successful years in the current premises, we have decided it is time to move. This is to ensure Ondine's customers enjoy the superior dining experience they deserve. In recent years this has been hampered by the ongoing works to the façade of the building that is occupied in part by Ondine. With no end in sight to these works I have decided relocation to new premises is important for Ondine's loyal customers. READ MORE: Our new opening in St Andrews in spring 2025 will be situated near the first tee at the world-famous Old Course, where the first ever game of golf was played 600 years ago. Seaton House offers 5-star luxury hospitality in the heart of historic St Andrews, with spectacular views across West Sands beach. Ondine Oyster & Grill will be a restaurant within the hotel working with the finest local producers from both land and sea. We also have Old Tom's Bar, providing... Brian DonnellyGreg Cote's Christmas Day and Thursday night NFL picksWEST PALM BEACH, Fla. (AP) — An online spat between factions of Donald Trump's supporters over immigration and the tech industry has thrown internal divisions in his political movement into public display, previewing the fissures and contradictory views his coalition could bring to the White House. The rift laid bare the tensions between the newest flank of Trump's movement — wealthy members of the tech world including billionaire Elon Musk and fellow entrepreneur Vivek Ramaswamy and their call for more highly skilled workers in their industry — and people in Trump's Make America Great Again base who championed his hardline immigration policies. The debate touched off this week when Laura Loomer , a right-wing provocateur with a history of racist and conspiratorial comments, criticized Trump’s selection of Sriram Krishnan as an adviser on artificial intelligence policy in his coming administration. Krishnan favors the ability to bring more skilled immigrants into the U.S. Loomer declared the stance to be “not America First policy” and said the tech executives who have aligned themselves with Trump were doing so to enrich themselves. Much of the debate played out on the social media network X, which Musk owns. Loomer's comments sparked a back-and-forth with venture capitalist and former PayPal executive David Sacks , whom Trump has tapped to be the “White House A.I. & Crypto Czar." Musk and Ramaswamy, whom Trump has tasked with finding ways to cut the federal government , weighed in, defending the tech industry's need to bring in foreign workers. It bloomed into a larger debate with more figures from the hard-right weighing in about the need to hire U.S. workers, whether values in American culture can produce the best engineers, free speech on the internet, the newfound influence tech figures have in Trump's world and what his political movement stands for. Trump has not yet weighed in on the rift. His presidential transition team did not respond to questions about positions on visas for highly skilled workers or the debate between his supporters online. Instead, his team instead sent a link to a post on X by longtime adviser and immigration hard-liner Stephen Miller that was a transcript of a speech Trump gave in 2020 at Mount Rushmore in which he praised figures and moments from American history. Musk, the world's richest man who has grown remarkably close to the president-elect , was a central figure in the debate, not only for his stature in Trump's movement but his stance on the tech industry's hiring of foreign workers. Technology companies say H-1B visas for skilled workers, used by software engineers and others in the tech industry, are critical for hard-to-fill positions. But critics have said they undercut U.S. citizens who could take those jobs. Some on the right have called for the program to be eliminated, not expanded. Born in South Africa, Musk was once on an a H-1B visa himself and defended the industry's need to bring in foreign workers. “There is a permanent shortage of excellent engineering talent," he said in a post. “It is the fundamental limiting factor in Silicon Valley.” Trump's own positions over the years have reflected the divide in his movement. His tough immigration policies, including his pledge for a mass deportation, were central to his winning presidential campaign. He has focused on immigrants who come into the U.S. illegally but he has also sought curbs on legal immigration , including family-based visas. As a presidential candidate in 2016, Trump called the H-1B visa program “very bad” and “unfair” for U.S. workers. After he became president, Trump in 2017 issued a “Buy American and Hire American” executive order , which directed Cabinet members to suggest changes to ensure H-1B visas were awarded to the highest-paid or most-skilled applicants to protect American workers. Trump's businesses, however, have hired foreign workers, including waiters and cooks at his Mar-a-Lago club , and his social media company behind his Truth Social app has used the the H-1B program for highly skilled workers. During his 2024 campaign for president, as he made immigration his signature issue, Trump said immigrants in the country illegally are “poisoning the blood of our country" and promised to carry out the largest deportation operation in U.S. history. But in a sharp departure from his usual alarmist message around immigration generally, Trump told a podcast this year that he wants to give automatic green cards to foreign students who graduate from U.S. colleges. “I think you should get automatically, as part of your diploma, a green card to be able to stay in this country," he told the “All-In" podcast with people from the venture capital and technology world. Those comments came on the cusp of Trump's budding alliance with tech industry figures, but he did not make the idea a regular part of his campaign message or detail any plans to pursue such changes.

What is DRG anyway? How Putrajaya plans to deal with rising medical costs with a new pricing system

Watch live: Climate Minister Simon Watts explains new emissions plan

MORRIS: Les Verts Living: Winnipeg’s best-kept secret for year-round fresh produceHow Far Can Tesla Stock Go After Nearing All-Time High in Massive Turnaround Year?

[Shang-Jin Wei] Institutional reforms China needs

WARREN, N.J., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, today expresses gratitude to shareholders for their unwavering support and trust in Tevogen Bio and its leadership. The commitment fuels the company’s determination to advance its mission of developing accessible, life-saving therapeutics. The company recently announced significant progress through its third quarter financial results for 2024, including, reduction of a net loss by $52.5 million, elimination of nearly all liabilities, and reiterating availability of sufficient capital to fund operations for the next 33 months. Ryan Saadi, MD, MPH, Founder and CEO, Tevogen Bio commented, "We remain steadfast in our mission to advance medical science, however as CEO of the company, preservation of shareholder value remains a priority. We urge all stakeholders to consider the profound impact short selling innovative healthcare companies has on lifesaving therapies. While stock price fluctuations are part of the public market dynamics, Tevogen Bio is acutely aware of the undue influence short sellers have.” William Keane, VP of Strategic Initiatives, and graduate of the FBI National Academy stated, “We are aware and monitoring the actions of potential short selling activity targeting our company. We will continue to bring light to this situation and will work with the appropriate authorities as needed.” The company plans to provide further updates on its progress in the coming weeks. About Tevogen Bio Tevogen is a clinical-stage specialty immunotherapy company harnessing one of nature’s most powerful immunological weapons, CD8+ cytotoxic T lymphocytes, to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the significant unmet needs of large patient populations. Tevogen Leadership believes that sustainability and commercial success in the current era of healthcare rely on ensuring patient accessibility through advanced science and innovative business models. Tevogen has reported positive safety data from its proof-of-concept clinical trial, and its key intellectual property assets are wholly owned by the company, not subject to any third-party licensing agreements. These assets include three granted patents, nine pending US and twelve ex-US pending patents, two of which are related to artificial intelligence. Tevogen is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and global product launch experience. Tevogen’s leadership believes that accessible personalized therapeutics are the next frontier of medicine, and that disruptive business models are required to sustain medical innovation. Forward-Looking Statements This press release contains certain forward-looking statements, including without limitation statements relating to: expectations regarding the healthcare and biopharmaceutical industries; Tevogen’s development of, the potential benefits of, and patient access to its product candidates for the treatment of infectious diseases, cancer and neurological disorders, including TVGN 489 for the treatment of COVID-19 and Long COVID; Tevogen’s ability to develop additional product candidates, including through use of Tevogen’s ExacTcell platform; the anticipated benefits of ExacTcell; expectations regarding Tevogen’s future clinical trials; and Tevogen’s ability to generate revenue in the future. Forward-looking statements can sometimes be identified by words such as “may,” “could,” “would,” “expect,” “anticipate,” “possible,” “potential,” “goal,” “opportunity,” “project,” “believe,” “future,” and similar words and expressions or their opposites. These statements are based on management’s expectations, assumptions, estimates, projections and beliefs as of the date of this press release and are subject to a number of factors that involve known and unknown risks, delays, uncertainties and other factors not under the company’s control that may cause actual results, performance or achievements of the company to be materially different from the results, performance or other expectations expressed or implied by these forward-looking statements. Factors that could cause actual results, performance, or achievements to differ from those expressed or implied by forward-looking statements include, but are not limited to: that Tevogen will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the effect of the recent business combination with Semper Paratus Acquisition Corporation (the “Business Combination”) on Tevogen’s business relationships, operating results, and business generally; the outcome of any legal proceedings that may be instituted against Tevogen; changes in the markets in which Tevogen competes, including with respect to its competitive landscape, technology evolution, or regulatory changes; changes in domestic and global general economic conditions; the risk that Tevogen may not be able to execute its growth strategies or may experience difficulties in managing its growth and expanding operations; the risk that Tevogen may not be able to develop and maintain effective internal controls; costs related to the Business Combination and the failure to realize anticipated benefits of the Business Combination; the failure to achieve Tevogen’s commercialization and development plans and identify and realize additional opportunities, which may be affected by, among other things, competition, the ability of Tevogen to grow and manage growth economically and hire and retain key employees; the risk that Tevogen may fail to keep pace with rapid technological developments to provide new and innovative products and services or make substantial investments in unsuccessful new products and services; the ability to develop, license or acquire new therapeutics; that Tevogen will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk of regulatory lawsuits or proceedings relating to Tevogen’s business; uncertainties inherent in the execution, cost, and completion of preclinical studies and clinical trials; risks related to regulatory review, approval and commercial development; risks associated with intellectual property protection; Tevogen’s limited operating history; and those factors discussed or incorporated by reference in Tevogen’s Annual Report on Form 10-K and subsequent filings with the SEC. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Tevogen undertakes no obligation to update any forward-looking statements, except as required by applicable law. Contacts Tevogen Bio Communications T: 1 877 TEVOGEN, Ext 701 Communications@Tevogen.com

How Far Can Tesla Stock Go After Nearing All-Time High in Massive Turnaround Year?Former CJI Chandrachud removed fear of law from political defectors, claims Shiv Sena (UBT) leader Sanjay RautLiam Payne's ex-girlfriend Sophia Smith has announced her engagement. The social media influencer has revealed the adorable moment her fiancé James Bridgwood asked for her hand in marriage over Christmas , the Mirror reports . Liam and Sophia, 30, met at St. Peter's Collegiate School in Wolverhampton, but they didn't date until 2013, splitting up two years later. Liam, who tragically died in October aged 31 after falling from a third-floor balcony of a hotel in Buenos Aires, had asked Sophia out more than 20 times before she agreed to date him. Sophia shared a clip of James popping the question in a spacious room in their home, surrounded by rose petals and a bottle of champagne as they relaxed in pyjamas, with their daughter, Angelina Grace, who she gave birth to in April 2023. Liam Payne died in October aged 31 (Image: Getty Images) Captioning the adorable upload, which was accompanied by Dan Berk's acoustic track, Anyone, Sophia said: "Yes a million times over. 25.12.24," alongside a read heart emoji. The star was seen emotional as she looked down at her ring while Angelina appeared blissfully unaware as she asked her parents to play with her dolls. Sophia, who has remained close to Liam's bandmates relatives and colleagues was flooded with celebratory messages. Lottie Tomlinson gushed: "Congratulations," alongside crying emojis and pink hearts. Lou Teasdale added: "Aw Soph," with a red heart. I'm A Celebrity star Maura Higgins typed: "Congratulations." One follower added: "Omggggggggg. Congratulations!!!!!!!" "Favourites forever can't stop watching this video," said a second. While a third went on to write: "Yayyyyy! So happy for you both! Congratulations."Need some assistance with NYT Strands today? Today's theme — "A visit from Santa" — is appropriately Christmas themed, so maybe you can draw inspiration from what's around you. Below, we've compiled some useful hints for Strands #297, as well as the answers, should it come to that. We'll start off with some clues, before building up to the full answer for Strands #297, so read on if you need a little help. Warning: Spoilers lie ahead for Strands #297. Today's NYT Strands answer — Today's theme and hints The official theme for NYT Strands #297 is... "A visit from Santa". And here's an unofficial hint from me: "Small gifts to wake up to." If you're still in the dark, here are some useful words to give you those valuable clue tokens: Still struggling? The spangram will give you a hint about the connection word. Today, it starts with S and ends with G. Scroll down to find out what it is... It's STOCKING. Today's Strands answers So, what are today's Strands answers for game #297? Drumroll, please... ...and the spangram was NATURENAMES. Strands #297 “A visit from Santa” 🔵🔵🟡🔵 🔵🔵🔵🔵 🔵 Hi Strands fans, and happy Christmas! Today's puzzle is appropriately themed for those who find time to play it, and it's simple enough that it shouldn't divert you from the joys of the day for too long. When I found ORANGE in the bottom-left corner, it immediately clicked that this was about stocking fillers, but before connecting the spangram of STOCKING, I went searching for the classic naughty-child gift. Sure enough, I found a lump of COAL on the right-hand side. The spangram then divided the grid in two, which made cleaning up pretty seamless. I found SOCKS in the top-right corner, with SCARF directly below it. I then noticed TOYS in the top-left corner, with PLUSHIE below to complete that side of the board. Two answers were left to find on the other side. CANDY was spelt backwards from the bottom upwards, and that just left PENS spelt downwards to finish the puzzle in time to return to some well-earned Christmas trash TV. Yesterday's Strands answers Reading this in a later time zone? You can find the full article on yesterday's Strands answers for game #296 right here .